Read our
White Paper
1 TMA token price
10€
Our Community
on Discord
Benefits: to increase the value of the token in case of price inflation and resale possibility on specialized markets
Benefits: interact with the medical cannabis industry and participate directly or indirectly in the adventure
Benefits: to take advantage of future opportunities that will be developed by Ashita Capital during the Taima venture
Ashita Capital
Why Choose Us
The Token is issued by Ashita, a Swiss start-up company based in Geneva. Ashita’s project is to finance a medical cannabis production company which will only accept Taima as a mean of payment for the fruits of its production. Ashita will do its utmost to promote and support the Taima.
Learn more about the benefits for the Taima tokenholders and the opportunity to invest indirectly or directly in the cannabis industry.
Our Tokens
What is Taima Coin?
Taima is a token that is intended to be used as a payment token. It is based on the Solana blockchain. It will allow the group’s customer to acquire the stock and production of Origami Pharma’s factories. The demand for Taima will increase in proportion to Origami’s production capacity which will increase the price of Taima. Essentially, Taima will be sold at the price of supply and demand. The creation of each factory will allow for a new annual demand for Taima by cannabis distribution companies who will want to buy from Origami. The Taima will therefore be a payment token that will be directly linked to the cannabis produced by Origami.
Market
The demand for medical and recreational cannabis is so much higher than the actual production capacity of the market. It is expected that every ton of production will be sold.
Production
For a production capacity of 250 million euro per year of flower it will take 250’000’000 of counter value in Taima to acquire it. Distributors will therefore have to acquire the equivalent in Taima. The million Taima in circulation will represent the value of the demand which will be 250
million in total for this year of production
million in total for this year of production
Circulation
The Origami Group is planning an expansion schedule of its production capacity that will allow it to produce more and more tons per year and therefore the demand for Taima will grow steadily. As Ashita does not plan to issue more Taima in the coming years, this will directly impact the number of Taima in circulation.
Benefits
The benefits for the Taima tokenholders lie in the acquisition of a crypto designed
to allow them to invest indirectly or directly in the cannabis industry. A payment token designed to increase in value concomitantly with the price of medical and recreational cannabis and the expansion of Origami Pharma SA
to allow them to invest indirectly or directly in the cannabis industry. A payment token designed to increase in value concomitantly with the price of medical and recreational cannabis and the expansion of Origami Pharma SA
Ashita will fund Origami to build a medical and recreational cannabis production
facility with an annual production capacity of 500 tons. This corresponds to a
funding of up to 800 million in total but not less than 40 million. The 40 million will allow for a start of origami production while waiting for the rest of the funding.
An issue of 20,000,000 Taima will be distributed as follows
1 TMA = 10€
Token distribution
- 20% Issuer / Ashita
- 50% Financing Project / Origami
- 10% Managing Team
- 5% Reserve
- 5% Cash Flow
- 10% Airdrop
Roadmap
Our Strategy and Project Plan
The first Swiss token backed by real economic value creation in the cannabis industry.
Our Team
Meet a Crew of Professionals
Michael Gebreziabiher
Director
Sujati Lo
CSO
Akito Tawil-Kummermann
Head of Marketing
Partners & Supporters
We Collaborate Only With The Best
Do not hesitate to contact us if you need further information.